Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 16, 2025 11:09 ET | Source: Trethera Corporation

Trethera Receives $2.7 Million NIH Grant, Validating the Potential of First-in-Class TRE-515 to Overcome KRAS Inhibitor Resistance in Lung Cancer

$2.7M NIH grant evaluates TRE-515 with KRAS inhibitors in lung cancer, boosting Trethera’s FDA Fast Track pipeline with a novel approach to resistance